The new screening program for cervical cancer aims to save lives by breaking down barriers that prevent women from attending screening, write Karen Canfell and Megan Smith.
As its name suggests, Gardasil 9 protects against nine types of HPV, five more than the existing Gardasil. Recent studies have shown it takes only two doses, with implications for cost and convenience, writes Terri Foran.
Researchers have found that in just four years the HPV vaccine has resulted in a dramatic drop in genital warts in young Australians of all backgrounds, a result that could herald good news for cervical cancer rates.
As the government considers recommendations for changes to cervical cancer screening, UNSW is a leading partner in a major trial of the new technology in Victoria.
Replacing two-yearly pap smears with five-yearly testing for the human papillomavirus (HPV) is expected to reduce cervical cancer rates even further, writes Karen Canfell.
The success of Australia’s multi-million dollar vaccination programs is compromised, with pockets of the population remaining at risk, according to a new report.
A vaccine used to prevent cervical cancer could also prevent some forms of breast cancer, saving tens of thousands of lives each year, a breakthrough study has found.
HIV/AIDS and kidney transplant patients are at much greater risk of contracting 20 different types of cancer than the general population, according to UNSW research published in The Lancet.
